Funding opportunity: MRC Developmental Pathway Funding Scheme - DPFS Stage one call

6 September 2023

• improve prevention, diagnosis, prognosis or treatment of significant health needs
• develop research tools that increase the efficiency of developing interventions

Stage 1 call deadline: 22 November 2023, 4.00pm.

Your project can start and finish at any stage on the developmental pathway from early development, through pre-clinical refinement and testing to early-phase clinical studies and trials (up to phase 2a). You can submit follow-on proposals where you can justify the need for continued support.

You can apply for funding for work on novel:

•     candidate therapeutic entities (for example, drug discovery)
•     vaccines for infectious or non-infectious disease
•     biologics (antibodies, peptides, proteins)
•     advanced therapeutics (for example, gene therapy and T-cell therapy)
•     regenerative medicine approaches
•     repurposing clinical studies or using existing therapies for new indications
•     medical devices
•     digital healthcare, app development or artificial intelligence
•     diagnostics (including biomarker validation)
•     medical imaging technology
•     surgical techniques or tools
•     behavioural and psychological interventions
•     radiotherapy and radiation protocols
•     interventions that benefit health in low and middle-income countries

Duration

There is no limit to the duration of your project. You should justify the timescale of the project in the context of the proposed work.

Funding available

There is no limit to the amount of funding you can apply for. You should justify the resources needed in the context of the proposed work.

Dr Sabari Vallath
Faculty Research Manager (VP Health)